| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/19/2013 | US8377887 Methods of reducing hypoxic stress in a mammal by administering soluble P-selectin |
| 02/19/2013 | US8377885 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| 02/19/2013 | US8377882 Stabilization of interleukin 6 in serum based solutions |
| 02/19/2013 | US8377879 Follicle stimulating hormone superagonists |
| 02/19/2013 | US8377878 Therapies for chronic renal failure |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | US8377701 Specific ligands to sortilin |
| 02/19/2013 | US8377690 Cells and methods for producing blocking antibodies to human RANKL |
| 02/19/2013 | US8377681 Evolution of whole cells and organisms by recursive sequence recombination |
| 02/19/2013 | US8377654 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
| 02/19/2013 | US8377477 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 02/19/2013 | US8377447 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells |
| 02/19/2013 | US8377438 Methods of antagonizing signal transduction in spinal cord cells |
| 02/19/2013 | CA2560981C Polymer-based sustained release device |
| 02/19/2013 | CA2556736C Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 02/19/2013 | CA2512780C Multivalent constructs that bind the vegf receptor-2 kdr for therapeutic and diagnostic applications |
| 02/19/2013 | CA2497279C Mutant forms of meningococcal adp-ribosylating toxin |
| 02/19/2013 | CA2487137C Tumour-associated peptides that bind to mhc molecules |
| 02/19/2013 | CA2480319C Chimeric delta endotoxin protein of cry1ea and cry1ca |
| 02/19/2013 | CA2469092C Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als) |
| 02/19/2013 | CA2467930C Treatment of pml targeting jc virus agno |
| 02/19/2013 | CA2467434C Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 02/19/2013 | CA2443088C Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 02/19/2013 | CA2426698C Method for producing proteins by electroporation |
| 02/19/2013 | CA2406236C Novel methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteins |
| 02/19/2013 | CA2388003C Expression of recombinant mature lysostaphin |
| 02/19/2013 | CA2375320C Dna vaccines for pets or for animals used in sports |
| 02/19/2013 | CA2233570C Detection, prevention and treatment of papillomatous digital dermatitis |
| 02/14/2013 | WO2013023070A2 Plants with altered glucuronoxylan methyl transferase activity and methods of use |
| 02/14/2013 | WO2013022808A2 Immunogenic protein conjugates and methods for making and using the same |
| 02/14/2013 | WO2013022738A1 P97 fragments with transfer activity |
| 02/14/2013 | WO2013022721A1 N-glycosylated insulin analogues |
| 02/14/2013 | WO2013022594A1 Transcription factors for the production of cellulose degrading enzymes |
| 02/14/2013 | WO2013022353A1 Methods for increasing co2 assimilation and oil production in photosynthetic organisms |
| 02/14/2013 | WO2013022328A1 Derivatives of recombinant proteins, homo-multimers of granulocyte colony-stimulating factor and method of preparation thereof |
| 02/14/2013 | WO2013022157A1 Pharmaceutical composition containing fibulin-3 protein as an active ingredient for inhibiting the growth of cancer stem cells |
| 02/14/2013 | WO2013022058A1 Bilirubin excretion enhancer |
| 02/14/2013 | WO2013021384A1 Compositions and methods for modulating apoptosis |
| 02/14/2013 | WO2013021377A1 Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |
| 02/14/2013 | WO2013021339A1 Proteins with pro-apoptotic and antitelomerase activity on cancer cells, their preparation and use |
| 02/14/2013 | WO2013021284A2 Anti-il-6 vaccine composition |
| 02/14/2013 | WO2013021206A2 Stable proteins |
| 02/14/2013 | WO2013021163A1 Peptide markers and uses thereof |
| 02/14/2013 | WO2013021063A2 Polypeptides having peroxygenase activity and polynucleotides encoding same |
| 02/14/2013 | WO2013020988A1 Pasteurellaceae vaccines |
| 02/14/2013 | WO2013020958A1 Use of macrocypins as pesticidal agents |
| 02/14/2013 | WO2013020951A1 Polynucleotide, polypeptide, animal model and method for the development of complement system modulators |
| 02/14/2013 | WO2013020831A1 Use of fmn-binding fluorescence proteins (fbfp) as new types of secretion markers |
| 02/14/2013 | WO2013020266A1 Anti-mouse stk40 polyclonal antibody and preparation thereof |
| 02/14/2013 | WO2012169940A9 Recombinant dna elements for the expression of recombinant proteins in insects |
| 02/14/2013 | WO2012169939A9 Recombinant dna elements for the expression of recombinant proteins in a host cell |
| 02/14/2013 | WO2012169798A3 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same |
| 02/14/2013 | WO2012082056A8 Novel biomarker and uses thereof in diagnosis, treatment of autism |
| 02/14/2013 | US20130041418 Methods for treating pulmonary hypertension and compositions comprising vasoactive intestinal peptide |
| 02/14/2013 | US20130041143 Polynucleotides encoding antibodies to cytokine receptor zcytor17 |
| 02/14/2013 | US20130041141 Fluorescent polymer composition |
| 02/14/2013 | US20130041138 Antibodies that bind to psca proteins for diagnosis of cancer |
| 02/14/2013 | US20130041132 Chemical preparation of ubiquitin thioesters and modifications thereof |
| 02/14/2013 | US20130041131 Glycosylated specificity exchangers |
| 02/14/2013 | US20130040900 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2013 | US20130040897 Glycosylation of proteins in host cells |
| 02/14/2013 | US20130040891 Chemically modified water-soluble elastin, mixed gel of chemically modified water-soluble elastin and collagen, and process for producing same |
| 02/14/2013 | US20130040888 Factor VIII Molecules With Reduced VWF Binding |
| 02/14/2013 | US20130040885 Collagen pad |
| 02/14/2013 | US20130040884 Albumin-binding conjugates comprising fatty-acid and peg |
| 02/14/2013 | US20130040883 Stable growth hormone compounds |
| 02/14/2013 | US20130040882 Use of fibroblast growth factor fragments |
| 02/14/2013 | US20130040877 Long-acting y2 receptor agonists |
| 02/14/2013 | US20130040836 Methods for engineering t-cell receptors |
| 02/14/2013 | US20130040391 Method for manufacturing glycoproteins having human-type glycosylation |
| 02/14/2013 | US20130040370 Novel Method for Vacuum-Assisted Preservation of Biologics Including Vaccines |
| 02/14/2013 | US20130040369 Gammaretrovirus Associated With Cancer |
| 02/14/2013 | US20130040322 Method of Diagnosing Sjogren's Disease |
| 02/14/2013 | US20130040310 Ulk1 compositions, inhibitors, screening and methods of use |
| 02/14/2013 | US20130040297 Process for the production of cells which are capable of converting arabinose |
| 02/14/2013 | US20130040284 Hbv drug resistance methods |
| 02/14/2013 | US20130039986 Silk-Based Ionomeric Compositions |
| 02/14/2013 | US20130039958 Method of vaccination |
| 02/14/2013 | US20130039948 Inhibition of TCR Signaling with Peptide Variants |
| 02/14/2013 | US20130039947 Novel immunogens and methods for discovery and screening thereof |
| 02/14/2013 | US20130039946 Vaccine comprising an attenuated pestivirus |
| 02/14/2013 | US20130039938 Highly efficient influenza matrix (m1) proteins |
| 02/14/2013 | US20130039935 Induction of tumor immunity by variants of folate binding protein |
| 02/14/2013 | US20130039934 Treatment of ige-mediated disease |
| 02/14/2013 | US20130039927 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| 02/14/2013 | US20130039914 Novel human genes relating to respiratory diseases and obesity |
| 02/14/2013 | US20130039902 Non-neurotoxic plasminogen activating factors for treating of stroke |
| 02/14/2013 | US20130039890 Treatment of tumors with genetically engineered herpes virus |
| 02/14/2013 | US20130039878 Triple cross-linked collagen, method of manufacturing the same, and use thereof |
| 02/14/2013 | CA2844749A1 Novel compositions and uses thereof |
| 02/14/2013 | CA2844434A1 Plants with altered glucuronoxylan methyl transferase activity and methods of use |
| 02/14/2013 | CA2844239A1 Methods for increasing co2 assimilation and oil production in photosynthetic organisms |
| 02/14/2013 | CA2843665A1 Anti-il-6 vaccine composition |
| 02/14/2013 | CA2843642A1 Use of dig3 insecticidal crystal protein in combination with cry1ab |
| 02/14/2013 | CA2843640A1 N-glycosylated insulin analogues |
| 02/14/2013 | CA2843558A1 Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |
| 02/14/2013 | CA2842492A1 P97 fragments with transfer activity |
| 02/13/2013 | EP2557157A1 Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand |
| 02/13/2013 | EP2557089A2 Compositions and methods for immunomodulation |